Probiotic composition for preventing and controlling diabetes and preparation method thereof

By extracting and modifying polysaccharides, active polyphenol-flavonoids, enzymatic proteins and probiotics, a probiotic-prebiotic-protein peptide embedded particle was prepared, solving the side effects and inconvenience of existing diabetes treatment methods. , effectively regulate blood sugar and blood lipids, and provide a safe, economical and effective management plan.

CN118987156APending Publication Date: 2024-11-22JIANGSU XINSHENAO BIOTECHNOLOGY CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202311563635.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-11-22
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing diabetes treatment methods have side effects, inconvenience and high cost problems, especially traditional oral drugs and insulin injections have put pressure on patients' health and economy, and the existing probiotic compositions are insufficient to regulate the taste and fragrance. Probiotics The number is small, making it difficult to effectively control blood sugar and blood lipids.

Method used

By extracting black fungus and shiitake polysaccharides and sulfate them, combining active polyphenol-flavonoids in noni pomace, blackberry pomace and purple-skinned garlic, enzymatically dissolve highland barley and rice bran proteins, metal ion chelation, and milk double ions are used. Probiotics such as Fibrobacterium are embedded into probiotic-prebiotic-protein peptide-embedded particles to form a probiotic composition for preventing and controlling diabetes.

Benefits of technology

This probiotic composition has significant antioxidant and anti-inflammatory effects, can regulate blood sugar and blood lipids, improve insulin sensitivity, reduce blood sugar fluctuations, and provide a safe, effective and economical diabetes management solution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004563211460000161
    Figure BDA0004563211460000161
  • Figure BDA0004563211460000171
    Figure BDA0004563211460000171
  • Figure BDA0004563211460000172
    Figure BDA0004563211460000172
Patent Text Reader

Abstract

The invention provides a probiotic composition for preventing and controlling diabetes and a preparation method thereof, and belongs to the technical field of probiotics. Performing sulfation modification on the black fungus and the lentinan to obtain sulfated modified polysaccharide; extracting morinda citrifolia pomace, blackberry pomace and purple garlic to obtain active polyphenol-flavone; highland barley and rice bran are subjected to enzymolysis and metal ion chelation, and chelated Mg-Zn-highland barley-rice bran protein peptide is obtained; solid residues generated in the process are inoculated with zymophyte for fermentation, a fermentation product and zymophyte liquid are obtained, the zymophyte liquid, prebiotics and chelated Mg-Zn-highland barley-rice bran protein peptide are embedded, and probiotic-prebiotics-protein peptide embedded particles are obtained; the probiotic composition for preventing and controlling the diabetes mellitus is prepared by mixing the raw materials with a fermentation product, sulfated modified polysaccharide and active polyphenol-flavone, and the probiotic composition is wide in raw material source and high in safety, has good antioxidant and anti-inflammatory effects, can well play roles in regulating blood sugar, blood fat and the like, and has a wide application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of probiotics, and in particular to a probiotic composition for preventing and controlling diabetes and a preparation method thereof. Background Art

[0002] Diabetes has become the third most serious chronic disease threatening human health after cancer and cardiovascular and cerebrovascular diseases. At the same time, it will seriously affect the cardiovascular and cerebrovascular system and kidneys. Among people with diabetes, more than 90% have type 2 diabetes. Type 2 diabetes is a chronic comprehensive disease that manifests symptoms of hyperglycemia due to the imbalance of blood sugar homeostasis. During the onset of the disease, carbohydrate and fat metabolism are disordered, affecting the normal physiological activities of organs and tissues throughout the body. The cause of type 2 diabetes is insulin resistance. The main clinical manifestations are polydipsia, polyuria, polyphagia and weight loss. The number of butyrate-producing bacteria in the human intestine decreases and the number of conditional pathogens increases, which can increase the inflammatory response in the intestine, leading to insulin resistance and then type 2 diabetes.

[0003] The existing traditional treatments for type 2 diabetes are mainly oral drugs: such as sulfonylureas, glinides, biguanides, thiazolidinediones and α-glucosidase inhibitors. Long-term use of this treatment method is prone to cause some side effects, such as diarrhea, dizziness, nausea, loss of appetite, hypoglycemia and liver damage, which seriously threaten people's health. In addition, injection of insulin or insulin analogs is also a way to lower blood sugar. However, multiple injections of drugs every day bring pain to diabetic patients, are expensive and accompanied by adverse reactions of hypoglycemia. Therefore, it is very necessary to explore safer, more effective and economical methods to relieve the symptoms of diabetes for the current situation, especially since the age of diabetic patients is generally younger, so safe and effective therapies are particularly important. In recent years, probiotics and prebiotics have gradually become a research hotspot for diabetes prevention and treatment due to their safety, easy availability, low cost and no side effects. Mixed preparations of probiotics and prebiotics can not only exert the physiological activity of probiotics, but also selectively increase the number of probiotics, making their effects more significant and lasting.

[0004] Chinese patent application CN107156587A discloses a kind of active probiotic solid beverage and its application in the treatment of type 2 diabetes, and its active probiotic solid beverage includes Lactobacillus reuteri, Lactobacillus rhamnosus, Bifidobacterium lactis, Aloe vera gel powder, resistant dextrin, galacto-oligosaccharide and auxiliary materials. After taking it, patients with mild to moderate type 2 diabetes have obvious reductions in short-term indicators of fasting blood sugar and 2-hour postprandial blood sugar and long-term indicators of glycosylated hemoglobin, and at the same time have lipid-lowering effects, can effectively reduce cholesterol, reduce triglycerides, increase high-density lipoprotein, and reduce low-density lipoprotein. However, it adds sweeteners, which can affect endocrine and body metabolism and increase the risk of diabetic complications.

[0005] Chinese patent CN110150669B discloses a probiotic composition suitable for edible by diabetic patients and its application, and the composition of the probiotic composition provided includes plant lactobacillus as plant lactobacillus YMC1005, acidophilus as acidophilus La28, bifidobacterium lactis as bifidobacterium lactis BAL531, and prebiotics. The prebiotics are selected from any one or more of resistant starch, resistant dextrin, oligofructose, inulin, oligoxylose, oligogalactose, stachyose, beta-glucan, grape seed powder, xylan, and arabinogalactan. The probiotic composition can be used as a functional food for type 2 diabetes patients, can improve the blood sugar status of type 2 diabetes patients, and is easy to eat and safe and reliable. However, it is only a combination of probiotics and prebiotics, without the auxiliary materials for adjusting taste and fragrance, and the number of probiotics used is less, and the number of bacteria that really play a role in the intestine is even less. Summary of the invention

[0006] The purpose of the present invention is to provide a probiotic composition for preventing and controlling diabetes and a preparation method thereof. The raw materials are from a wide range of sources and are all food-grade raw materials with high safety. It has good antioxidant and anti-inflammatory effects and can well regulate blood sugar and blood lipids. It is a good product for preventing and controlling type 2 diabetes and will have broad application prospects.

[0007] The technical solution of the present invention is achieved in this way:

[0008] The invention provides a preparation method of a probiotic composition for preventing and controlling diabetes. The method comprises the following steps: extracting black fungus and shiitake polysaccharides and performing sulfate modification to obtain sulfated modified polysaccharides; extracting noni pomace, blackberry pomace and purple garlic by deep eutectic solvent to obtain active polyphenol-flavonoids; enzymolyzing highland barley and rice bran, and chelating metal ions to obtain chelated Mg-Zn-highland barley-rice bran protein peptides; inoculating fermentation bacteria into solid residues produced in the above process for fermentation, filtering, washing the solids to collect the fermentation liquid, freeze-drying the filtrate to obtain a fermentation product, mixing the fermentation liquid with prebiotics and the chelated Mg-Zn-highland barley-rice bran protein peptides for embedding to obtain probiotic-prebiotic-protein peptide embedded particles, and mixing the fermentation product, the sulfated modified polysaccharide and the active polyphenol-flavonoids to obtain the probiotic composition for preventing and controlling diabetes.

[0009] As a further improvement of the present invention, the following steps are included:

[0010] S1. Extraction of active polysaccharides: Wash black fungus and shiitake mushrooms, dry and crush them to obtain a mixed powder 1, add them into water, heat them to boiling for extraction, filter and collect solid 1, add ethanol to the filtrate for precipitation, centrifuge, collect solids, wash and dry them to obtain active polysaccharides;

[0011] S2. Sulfated modified polysaccharide: In an ice water bath, concentrated sulfuric acid and n-butanol were mixed, ammonium sulfate and the active polysaccharide obtained in step S1 were added, the reaction was stirred, the pH value of the solution was adjusted to neutral, ethanol was added for precipitation, centrifugation was performed, the precipitate was collected, washed, and dried to obtain a sulfated modified polysaccharide;

[0012] S3. Extraction of active polyphenols-flavonoids: Noni pomace, blackberry pomace and purple garlic are washed, dried, crushed and mixed to obtain a mixed powder 2, a deep eutectic solvent and an ethanol solution are added, ultrasonic-assisted heating extraction is performed, centrifugation is performed, filtering is performed, solid 2 is collected, polyphenols and flavonoids are enriched and recovered in the filtrate using a macroporous resin, and the obtained polyphenols and flavonoids are uniformly mixed to obtain active polyphenols-flavonoids;

[0013] S4. Preparation of enzymatic protein peptide: The highland barley and rice bran were washed, dried, crushed and mixed to obtain a mixed powder 3, added to water, added with a composite enzyme for enzymatic hydrolysis, filtered, solid 3 was collected, the filtrate was dialyzed, and the dialyzate was freeze-dried to obtain highland barley - rice bran protein peptide;

[0014] S5. Metal ion chelation: The highland barley - rice bran protein peptide obtained in step S4 was dissolved in water, zinc salt and magnesium salt were added, the reaction was stirred, dialyzed, and the dialyzate was freeze-dried to obtain a chelated Mg-Zn-highland barley - rice bran protein peptide;

[0015] S6. Activation of fermentation bacteria: Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 were inoculated into Gao's medium and activated under anoxic conditions to obtain a seed solution of the bacteria;

[0016] S7 fermentation: solid 1, solid 2, solid 3 was mixed and added to water, sterilized, inoculated with the seed solution of Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, Bifidobacterium breve BB033 obtained in step S6, fermented under anoxic conditions, filtered, washed with solids, the culture solution was collected, concentrated to obtain a mixed culture solution; the filtrate was freeze-dried to obtain a fermentation product;

[0017] S8. Preparation of prebiotics: mixing inulin, sodium alginate and carboxymethyl pachymaran to prepare prebiotics;

[0018] S9. Encapsulation: adding the chelated Mg-Zn-highland barley-rice bran protein peptide obtained in step S5 to the mixed bacterial solution obtained in step S7, adding the prebiotics and lecithin obtained in step S7, stirring and mixing uniformly to obtain an aqueous phase; adding the aqueous phase to fish oil, emulsifying, adding a calcium chloride solution dropwise, solidifying at room temperature, centrifuging, washing, and drying to obtain probiotic-prebiotic-protein peptide embedded particles;

[0019] S10. Preparation of a probiotic composition for preventing and controlling diabetes: uniformly mix the sulfated modified polysaccharide prepared in step S2, the active polyphenol-flavonoids prepared in step S3, the fermentation product prepared in step S7, and the probiotic-prebiotic-protein peptide-encapsulated particles prepared in step S9 to prepare a probiotic composition for preventing and controlling diabetes.

[0020] As a further improvement of the present invention, the mass ratio of black fungus and shiitake mushroom in step S1 is 7-10:3-5, the solid-liquid ratio of the mixed powder 1 and water is 1:5-7g / mL, the extraction time is 3-5h, ethanol is added until the ethanol content of the system is 75-85wt%, and the precipitation time is 2-4h; the mass ratio of concentrated sulfuric acid, n-butanol, ammonium sulfate and active polysaccharide in step S2 is 22-35:7-10:0.3-0.5:3-5, the stirring reaction time is 0.5-1h, ethanol is added until the ethanol content of the system is 75-85wt%, and the precipitation time is 2-4h.

[0021] As a further improvement of the present invention, the mass ratio of the noni pomace, the blackberry pomace, and the purple garlic in step S3 is 10-12:7-10:5-7, the mass ratio of the mixed powder 2, the deep eutectic solvent, and the ethanol solution is 10-12:15-20:12-15, the concentration of the ethanol solution is 50-60wt%, the deep eutectic solvent is lactic acid and choline chloride, the molar ratio is 1.8-2.2:1, the temperature of the ultrasonic assisted heating extraction is 55-65°C, the time is 1-2h, the ultrasonic power is 1200-1500W, and the macroporous resin is selected from NKA-9, D1 01, HPD600, XDA-2, X-5, LSA-10, NKI-9, SP-825, AB-8; the mass ratio of highland barley and rice bran in step S4 is 12-15:3-5, the solid-liquid ratio of the mixed powder 3 and water is 1:3-5g / mL, the composite enzyme is papain and neutral protease, the mass ratio is 5-7:1-2, the addition amount of the composite enzyme is 1-2wt% of the total mass of the system, the temperature of the enzymolysis is 45-50°C, the time is 2-4h, the pore size of the dialysis bag used for dialysis is 3-5kDa, and the dialysis time is 2-4h.

[0022] As a further improvement of the present invention, the mass ratio of highland barley-rice bran protein peptide, zinc salt and magnesium salt in step S5 is 15-20:1-2:2-4, the magnesium salt is selected from at least one of magnesium chloride, magnesium sulfate and magnesium nitrate, the zinc salt is selected from at least one of zinc chloride, zinc sulfate and zinc nitrate, the stirring reaction time is 20-30min, the dialysis bag pore size for dialysis is 3-5kDa, and the dialysis time is 2-4h; the conditions for activation culture in step S6 are 36-38°C, 150-200r / min, activation culture 24-28h, and the bacterial content of the bacterial seed liquid is 10 8 -10 9 cfu / mL.

[0023] As a further improvement of the present invention, the mass ratio of solid 1, solid 2, solid 3 and water in step S7 is 10-12:7-10:5-7:500, the inoculation amount of the seed solution of Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 is 1-3v / v%, 1-2v / v%, and 2-3v / v%, respectively, and the fermentation culture conditions are 36-38°C, 120-150r / min, and the fermentation culture is 48-56h, and the bacterial content in the mixed bacterial solution is 10 10 -10 11 cfu / mL; the mass ratio of inulin, sodium alginate and carboxymethyl pachymaran in step S8 is 4-6:12-15:3-5.

[0024] As a further improvement of the present invention, the mass ratio of the chelated Mg-Zn-highland barley-rice bran protein peptide, the mixed bacterial liquid, the prebiotics and the lecithin in step S9 is 5-7:30-50:15-17:0.5-1; the mass ratio of the sulfated modified polysaccharide, the active polyphenol-flavonoids, the fermentation product, and the probiotic-prebiotic-protein peptide embedded particles in step S10 is 3-5:2-4:7-10:10-12.

[0025] As a further improvement of the present invention, the present invention specifically comprises the following steps:

[0026] S1. Extraction of active polysaccharides: 7-10 parts by weight of black fungus and 3-5 parts by weight of shiitake mushrooms were washed, dried, and crushed to obtain a mixed powder 1, added to water, the solid-liquid ratio of the mixed powder 1 to water was 1:5-7 g / mL, heated to boiling and extracted for 3-5 hours, filtered, and solid 1 was collected, ethanol was added to the filtrate until the ethanol content of the system was 75-85wt%, precipitated for 2-4 hours, centrifuged, the solid was collected, washed, and dried to obtain active polysaccharides;

[0027] S2. Sulfated modified polysaccharide: In an ice water bath, 22-35 parts by weight of concentrated sulfuric acid and 7-10 parts by weight of n-butanol are mixed, 0.3-0.5 parts by weight of ammonium sulfate and 3-5 parts by weight of the active polysaccharide obtained in step S1 are added, the reaction is stirred for 0.5-1h, the pH value of the solution is adjusted to neutral, ethanol is added to the system ethanol content of 75-85wt%, precipitation is carried out for 2-4h, centrifugation is carried out, the precipitate is collected, washed, and dried to obtain a sulfated modified polysaccharide;

[0028] S3. Extraction of active polyphenols-flavonoids: 10-12 parts by weight of noni pomace, 7-10 parts by weight of blackberry pomace, and 5-7 parts by weight of purple garlic are washed, dried, crushed and mixed to obtain a mixed powder 2, 10-12 parts by weight of the mixed powder 2 are added with 15-20 parts by weight of a deep eutectic solvent and 12-15 parts by weight of a 50-60wt% ethanol aqueous solution, 1200-1500W ultrasonic-assisted, heated to 55-65°C, extracted for 1-2h, centrifuged, filtered, and solid 2 is collected, the filtrate is enriched and recovered with a macroporous resin for polyphenols and flavonoids, the obtained polyphenols and flavonoids are mixed uniformly, and active polyphenols-flavonoids are obtained;

[0029] The deep eutectic solvent is lactic acid and choline chloride in a molar ratio of 1.8-2.2:1;

[0030] Macroporous resin AB-8 was used to enrich and recover flavonoids, and NKA-2 was used to enrich and recover polyphenols.

[0031] S4. Preparation of enzymatic protein peptide: 12-15 parts by weight of highland barley and 3-5 parts by weight of rice bran were washed, dried, crushed and mixed to obtain a mixed powder 3, added to water, the solid-liquid ratio of the mixed powder 3 and water was 1:3-5g / mL, a complex enzyme was added, the addition amount was 1-2wt% of the total mass of the system, 45-50°C enzymatic hydrolysis for 2-4h, filtered, solid 3 was collected, the filtrate was dialyzed with a dialysis bag with a pore size of 3-5kDa for 2-4h, and the dialyzate was freeze-dried to obtain highland barley-rice bran protein peptide;

[0032] The complex enzyme is papain and neutral protease, with a mass ratio of 5-7:1-2;

[0033] S5. Metal ion chelation: 15-20 parts by weight of the highland barley - rice bran protein peptide obtained in step S4 was dissolved in 200 parts by weight of water, 1-2 parts by weight of zinc salt and 2-4 parts by weight of magnesium salt were added, the reaction was stirred for 20-30 min, dialyzed with a dialysis bag with a pore size of 3-5 kDa for 2-4 h, and the dialysate was freeze-dried to obtain a chelated Mg-Zn-highland barley - rice bran protein peptide;

[0034] S6. Activation of fermentation bacteria: Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 were inoculated into Gao's medium respectively, and activated and cultured for 24-28 hours at 36-38°C and 150-200r / min under anoxic conditions to obtain a bacterial seed solution with a bacterial content of 10 8 -10 9 cfu / mL;

[0035] S7. Fermentation: 10-12 parts by weight of solid 1, 7-10 parts by weight of solid 2, 5-7 parts by weight of solid 3 were mixed and added to 500 parts by weight of water, sterilized, inoculated with the seed solution of Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, Bifidobacterium breve BB033 obtained in step S6, and the inoculation amounts were 1-3v / v%, 1-2v / v%, 2-3v / v%, respectively, under anaerobic conditions, 36-38°C, 120-150r / min, fermented and cultured for 48-56h, filtered, washed with solids, the culture solution was collected, concentrated, and a mixed culture solution containing 10 10 -10 11 cfu / mL; the filtrate was freeze-dried to obtain the fermentation product;

[0036] S8. Preparation of prebiotics: 4-6 parts by weight of inulin, 12-15 parts by weight of sodium alginate, and 3-5 parts by weight of carboxymethyl pachymaran were mixed to obtain prebiotics;

[0037] S9. Encapsulation: Add 5-7 parts by weight of the chelated Mg-Zn-barley-rice bran protein peptide prepared in step S5 to 30-50 parts by weight of the mixed bacterial solution prepared in step S7, add 15-17 parts by weight of the prebiotic prepared in step S7 and 0.5-1 parts by weight of lecithin, stir and mix evenly to obtain an aqueous phase; add 100-120 parts by weight of the aqueous phase to 200 parts by weight of fish oil, emulsify, add 20 parts by weight of 5-7wt% calcium chloride solution dropwise, cure at room temperature for 20-30min, centrifuge, wash, and dry to obtain probiotics-prebiotics-protein peptide embedded particles;

[0038] S10. Preparation of a probiotic composition for preventing and controlling diabetes: 3-5 parts by weight of the sulfated modified polysaccharide prepared in step S2, 2-4 parts by weight of the active polyphenol-flavonoids prepared in step S3, 7-10 parts by weight of the fermentation product prepared in step S7, and 10-12 parts by weight of the probiotic-prebiotic-protein peptide embedded particles prepared in step S9 are uniformly mixed to prepare a probiotic composition for preventing and controlling diabetes.

[0039] The present invention further protects a probiotic composition for preventing and controlling diabetes prepared by the above preparation method.

[0040] The present invention further protects the use of the above-mentioned probiotic composition for preventing and controlling diabetes in the preparation of food and medicine for preventing, treating and assisting in the treatment of type 2 diabetes.

[0041] The present invention has the following beneficial effects:

[0042] Black fungus and shiitake mushrooms are rich in active polysaccharides that can lower blood sugar. They have the ability to promote insulin secretion and enhance insulin sensitivity, reduce oxidative stress and inflammatory response, and thus improve β-cell damage. After the active polysaccharide is extracted, it is modified by sulfation to further improve the stability of the modified polysaccharide, improve its antioxidant, blood sugar lowering, blood lipid regulating activities, and have a good effect of inhibiting active enzymes such as α-glucosidase and α-amylase. By inhibiting the activity of these enzymes, the starch food intake is reduced and decomposed into oligosaccharides, which are further converted into monosaccharides by α-glucosidase in the small intestine, thereby inhibiting the increase in blood sugar caused by the conversion of food into monosaccharides and absorption into the blood, and inducing hepatocytes to produce insulin, so that postprandial blood sugar can be well stabilized. In addition, the modified polysaccharide can also increase the probiotics, promote the production of short-chain fatty acids, promote the intestinal peristalsis of rats, reduce the pH in the intestine, provide a good living environment for probiotics, promote the increase in the content of short-chain fatty acids (acetic acid, propionic acid, isobutyric acid, etc.) in the body, and reduce blood sugar.

[0043] Noni is a fruit that contains vitamins, amino acids, phenolic compounds, organic acids, polysaccharides, alkaloids, anthraquinones, cyclopentane compounds, scopolamine and other functional active ingredients. It has good anti-tumor, anti-thrombotic, antibacterial, hypoglycemic activities, as well as the activities of activating the immune system, neutralizing free radicals, balancing cell functions, cleaning blood and regulating cholesterol. Blackberries are also rich in anthocyanins, flavonoids and other active substances, which have antioxidant, hypoglycemic, inflammatory and cardiovascular disease prevention and anti-cancer effects. Purple garlic is rich in sulfur compounds, volatile oils, amino acids, polysaccharides, vitamins, saponin compounds, polyphenolic compounds, flavonoid compounds, biologically active enzymes and trace elements, and has good anti-inflammatory, antioxidant, hypoglycemic, cardiovascular disease prevention and treatment, anti-tumor, and lipid-lowering activities. The present invention utilizes the pomace (noni pomace, blackberry pomace) after industrial juicing to extract a polyphenol composition and a flavonoid composition with excellent anti-inflammatory and antioxidant activities together with purple garlic. The extraction is performed by a deep eutectic solvent, which is economical, non-toxic, recyclable, and environmentally friendly, and has a high extraction rate for polyphenols and flavonoids. Under the auxiliary extraction of ultrasound, the extraction rate of the original polyphenols and flavonoids is greatly improved. The obtained active polyphenol-flavonoids have excellent antioxidant and anti-inflammatory activities, have excellent inhibitory activity on α-glucosidase and α-amylase, and also play a good role in regulating blood sugar.

[0044] Highland barley and rice bran are rich in protein. The small molecule protein peptides obtained by enzymatic hydrolysis have good hypoglycemic, hypolipidemic, anti-inflammatory and antioxidant activities. The small molecule structure makes it easier to be absorbed by the human body. The prepared protein peptides are further chelated with trace element ions Mg ions and Zn ions through coordination bonds to obtain protein peptides containing trace elements Mg and Zn. Magnesium or zinc can promote insulin secretion, thereby regulating blood sugar.

[0045] Probiotics regulate blood sugar by regulating intestinal flora balance, intestinal immunity, microorganism-intestine-brain axis, microorganism-intestine-liver axis, etc. The added Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 of the present invention can act synergistically and play a good role in regulating blood sugar. On the one hand, after these probiotics enter the intestine, they can rapidly proliferate and consume glucose, and by reducing chronic low-grade inflammation, reducing serum lipopolysaccharide, free fatty acids, TNF-α, IL-6, IL-8 levels and increasing IL-10 levels, significantly improve the inflammatory state induced by serum lipopolysaccharide, reduce oxidative stress, improve insulin resistance, etc. to achieve the effect of regulating blood sugar. At the same time, these probiotics can produce a large amount of postbiotics, including microbial metabolites, proteins, lipids, carbohydrates, vitamins, organic acids, cell wall components or other complex molecules, etc., participate in immune regulation or stimulate intestinal cells to play a role, wherein acetate has been shown to reduce inflammation and insulin sensitivity and improve glucose tolerance by regulating fasting insulin and glucagon levels. The dipeptide in the bacterial wall can regulate the secretion of GLP-1 and improve insulin sensitivity and glucose tolerance through the NOD2 receptor. Combinations of bacteria, synbiotics, and postbiotics have good biological activity and can prevent and alleviate metabolic diseases such as type 2 diabetes. Bacteriocins can protect the pancreatic islets, promote the function of the pancreatic islets, inhibit α-glucosidase, and regulate blood sugar.

[0046] The probiotics added in the present invention can also ferment the solid waste residue of the previous step to further break the cell wall, promote the dissolution of active components in the plant, and produce a large amount of short-chain fatty acids and other substances. The obtained fermentation product also has good antioxidant and anti-inflammatory effects, and can well regulate blood sugar, blood lipids and other metabolic effects.

[0047] However, if probiotics enter the human body directly, they are often destroyed and inactivated by gastric acid, and cannot smoothly reach the intestine to exert their effects. Therefore, the present invention encapsulates probiotics and chelated protein peptides. On the one hand, the embedded wall material is a type of polysaccharide substance, which has good gastric acid and choline resistance after mixed encapsulation. On the other hand, these polysaccharide wall materials are also a good prebiotic. After being degraded and ruptured in the intestine, the probiotics inside are dissolved and colonized in the intestine. The ruptured prebiotic wall materials can be effectively utilized by the prebiotics, thereby greatly promoting the reproduction of probiotics and the secretion of postbiotics such as short-chain fatty acids, which greatly promotes the regulation of blood sugar by probiotics. The protein peptides also avoid inactivation by gastric acid, can be directly absorbed by the human body after entering the intestine, and exert good antioxidant, anti-inflammatory and blood sugar regulating effects.

[0048] The probiotic composition for preventing and controlling diabetes prepared by the present invention has a wide source of raw materials, all of which are food-grade raw materials, are highly safe, have good antioxidant and anti-inflammatory effects, can well regulate blood sugar and blood lipids, etc., is a very good product for preventing and controlling type 2 diabetes, and will have broad application prospects. DETAILED DESCRIPTION

[0049] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0050] Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 were provided by our company, and the deposit information is as follows:

[0051] Bifidobacterium lactis Bla019, classified and named as Bifidobacterium lactis, with the deposit number of CGMCC NO.17055 and the deposit date of January 2, 2019, is deposited at the General Microbiology Center of China Culture Collection Administration, address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, Postal Code: 100101.

[0052] Bifidobacterium longum BL5b, classified and named as Bifidobacterium longum, with a preservation number of CGMCC NO.17056 and a preservation date of January 2, 2019. The depository is the General Microbiology Center of China Culture Collection Administration, address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, Postal Code: 100101.

[0053] Bifidobacterium breve BB033, classified and named Bifidobacterium breve, with a preservation number of CGMCC NO.22777 and a preservation date of June 24, 2021. The preservation unit is the General Microbiology Center of China Culture Collection Administration, address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, Postal Code: 100101.

[0054] Papain, 10,000 U / g, was purchased from Merck China Ltd.; neutral protease, 20,000 U / g, was purchased from Shandong Siyang Biotechnology Co., Ltd.

[0055] Example 1

[0056] This embodiment provides a method for preparing a probiotic composition for preventing and controlling diabetes, which specifically comprises the following steps:

[0057] S1. Extraction of active polysaccharides: 7 parts by weight of black fungus and 3 parts by weight of shiitake mushrooms were washed, dried, and crushed to obtain a mixed powder 1, which was added to water. The solid-liquid ratio of the mixed powder 1 to water was 1:5 g / mL. The mixture was heated to boiling and extracted for 3 hours. The solid 1 was collected by filtration. Ethanol was added to the filtrate until the ethanol content of the system was 75 wt%. The mixture was precipitated for 2 hours, centrifuged, the solid was collected, washed, and dried to obtain active polysaccharides.

[0058] S2. Sulfated modified polysaccharide: In an ice water bath, 22 parts by weight of concentrated sulfuric acid and 7 parts by weight of n-butanol were mixed, 0.3 parts by weight of ammonium sulfate and 3 parts by weight of the active polysaccharide obtained in step S1 were added, the reaction was stirred for 0.5 h, the pH value of the solution was adjusted to neutral, ethanol was added until the ethanol content of the system was 75 wt%, and the precipitation was carried out for 2 h, centrifuged, the precipitate was collected, washed, and dried to obtain a sulfated modified polysaccharide;

[0059] S3. Extraction of active polyphenols-flavonoids: 10 parts by weight of noni pomace, 7 parts by weight of blackberry pomace, and 5 parts by weight of purple garlic were washed, dried, crushed and mixed to obtain a mixed powder 2, 10 parts by weight of the mixed powder 2 were added with 15 parts by weight of a deep eutectic solvent and 12 parts by weight of a 50 wt% ethanol aqueous solution, 1200 W ultrasonic assisted, heated to 55 ° C, extracted for 1 hour, centrifuged, filtered, and solid 2 was collected, the filtrate was enriched and recovered with a macroporous resin for polyphenols and flavonoids, the obtained polyphenols and flavonoids were mixed uniformly, and active polyphenols-flavonoids were obtained;

[0060] The deep eutectic solvent is lactic acid and choline chloride in a molar ratio of 1.8:1;

[0061] The flavonoids were enriched and recovered by using macroporous resin AB-8 and eluted with 60% ethanol; the polyphenols were enriched and recovered by using NKA-2 and eluted with 30% ethanol;

[0062] S4. Preparation of enzymatic protein peptide: 12 parts by weight of highland barley and 3 parts by weight of rice bran were washed, dried, crushed and mixed to obtain a mixed powder 3, which was added to water. The solid-liquid ratio of the mixed powder 3 to water was 1:3 g / mL. A composite enzyme was added in an amount of 1wt% of the total mass of the system. The enzyme was hydrolyzed at 45°C for 2h, filtered, and the solid 3 was collected. The filtrate was dialyzed with a dialysis bag with a pore size of 5 kDa for 2h, and the dialyzate was freeze-dried to obtain highland barley-rice bran protein peptide;

[0063] The composite enzyme is papain and neutral protease, with a mass ratio of 5:1;

[0064] S5. Metal ion chelation: 15 parts by weight of the highland barley - rice bran protein peptide obtained in step S4 was dissolved in 200 parts by weight of water, 1 part by weight of zinc chloride and 2 parts by weight of magnesium chloride were added, the reaction was stirred for 20 min, dialyzed with a dialysis bag with a pore size of 5 kDa for 2 h, and the dialysate was freeze-dried to obtain a chelated Mg-Zn-highland barley - rice bran protein peptide;

[0065] S6. Activation of fermentation bacteria: Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 were inoculated into Gao's medium respectively, and activated and cultured for 24 hours at 36°C and 150r / min under anoxic conditions to obtain a bacterial seed solution with a bacterial content of 10 8 cfu / mL;

[0066] S7. Fermentation: 10 parts by weight of solid 1, 7 parts by weight of solid 2, and 5 parts by weight of solid 3 were mixed and added to 500 parts by weight of water, sterilized, and inoculated with the seed solution of Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 obtained in step S6, and the inoculation amounts were 1v / v%, 1v / v%, and 2v / v%, respectively, under anaerobic conditions, 36°C, 120r / min, and fermented for 48h, filtered, washed with solids, and the culture solution was collected and concentrated to obtain a mixed culture solution containing 10 10 cfu / mL; the filtrate was freeze-dried to obtain the fermentation product;

[0067] S8. Preparation of prebiotics: 4 parts by weight of inulin, 12 parts by weight of sodium alginate, and 3 parts by weight of carboxymethyl pachymaran were mixed to obtain prebiotics;

[0068] S9. Encapsulation: Add 5 parts by weight of the chelated Mg-Zn-highland barley-rice bran protein peptide prepared in step S5 to 30 parts by weight of the mixed bacterial solution prepared in step S7, add 15 parts by weight of the prebiotics prepared in step S7 and 0.5 parts by weight of lecithin, stir and mix for 15 minutes to obtain an aqueous phase; add 100 parts by weight of the aqueous phase to 200 parts by weight of fish oil, emulsify at 10000 r / min for 15 minutes, add 20 parts by weight of a 5wt% calcium chloride solution dropwise, solidify at room temperature for 20 minutes, centrifuge, wash, and dry to obtain probiotics-prebiotics-protein peptide embedded particles;

[0069] S10. Preparation of a probiotic composition for preventing and controlling diabetes: 3 parts by weight of the sulfated modified polysaccharide prepared in step S2, 2 parts by weight of the active polyphenol-flavonoids prepared in step S3, 7 parts by weight of the fermentation product prepared in step S7, and 10 parts by weight of the probiotic-prebiotic-protein peptide embedded particles prepared in step S9 are stirred and mixed for 15 minutes to prepare a probiotic composition for preventing and controlling diabetes.

[0070] Example 2

[0071] This embodiment provides a method for preparing a probiotic composition for preventing and controlling diabetes, which specifically comprises the following steps:

[0072] S1. Extraction of active polysaccharides: 10 parts by weight of black fungus and 5 parts by weight of shiitake mushrooms were washed, dried, and crushed to obtain a mixed powder 1, which was added to water. The solid-liquid ratio of the mixed powder 1 to water was 1:7 g / mL. The mixture was heated to boiling and extracted for 5 hours. The solid 1 was collected by filtration. Ethanol was added to the filtrate until the ethanol content of the system was 85 wt %. The mixture was precipitated for 4 hours, centrifuged, the solid was collected, washed, and dried to obtain active polysaccharides.

[0073] S2. Sulfated modified polysaccharide: In an ice water bath, 35 parts by weight of concentrated sulfuric acid and 10 parts by weight of n-butanol were mixed, 0.5 parts by weight of ammonium sulfate and 5 parts by weight of the active polysaccharide obtained in step S1 were added, the reaction was stirred for 1 hour, the pH value of the solution was adjusted to neutral, ethanol was added until the ethanol content of the system was 85wt%, precipitation was carried out for 4 hours, centrifuged, the precipitate was collected, washed, and dried to obtain a sulfated modified polysaccharide;

[0074] S3. Extraction of active polyphenols-flavonoids: 12 parts by weight of noni pomace, 10 parts by weight of blackberry pomace, and 7 parts by weight of purple garlic were washed, dried, crushed and mixed to obtain a mixed powder 2, 12 parts by weight of the mixed powder 2 were added with 20 parts by weight of a deep eutectic solvent and 15 parts by weight of a 60wt% ethanol aqueous solution, 1500W ultrasonic assisted, heated to 65°C, extracted for 2h, centrifuged, filtered, and solid 2 was collected, the filtrate was enriched and recovered with a macroporous resin for polyphenols and flavonoids, the obtained polyphenols and flavonoids were mixed uniformly, and active polyphenols-flavonoids were obtained;

[0075] The deep eutectic solvent is lactic acid and choline chloride in a molar ratio of 2.2:1;

[0076] The flavonoids were enriched and recovered by using macroporous resin AB-8 and eluted with 60% ethanol; the polyphenols were enriched and recovered by using NKA-2 and eluted with 30% ethanol;

[0077] S4. Preparation of enzymatic protein peptide: 15 parts by weight of highland barley and 5 parts by weight of rice bran were washed, dried, crushed and mixed to obtain a mixed powder 3, added to water, the solid-liquid ratio of the mixed powder 3 to water was 1:5 g / mL, a composite enzyme was added, the addition amount was 2wt% of the total mass of the system, enzymolysis was performed at 50°C for 4h, filtered, solid 3 was collected, the filtrate was dialyzed with a dialysis bag with a pore size of 3kDa for 4h, and the dialyzate was freeze-dried to obtain highland barley-rice bran protein peptide;

[0078] The composite enzyme is papain and neutral protease, with a mass ratio of 7:2;

[0079] S5. Metal ion chelation: 20 parts by weight of the highland barley - rice bran protein peptide obtained in step S4 were dissolved in 200 parts by weight of water, 2 parts by weight of zinc sulfate and 4 parts by weight of magnesium sulfate were added, the reaction was stirred for 30 min, dialyzed for 4 h with a dialysis bag having a pore size of 3 kDa, and the dialysate was freeze-dried to obtain a chelated Mg-Zn-highland barley - rice bran protein peptide;

[0080] S6. Activation of fermentation bacteria: Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 were inoculated into Gao's medium respectively, and activated and cultured for 28 hours at 38°C and 200r / min under anoxic conditions to obtain a bacterial seed solution with a bacterial content of 10 9 cfu / mL;

[0081] S7. Fermentation: 12 parts by weight of solid 1, 10 parts by weight of solid 2, and 7 parts by weight of solid 3 were mixed and added to 500 parts by weight of water, sterilized, and inoculated with the seed solution of Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 obtained in step S6, and the inoculation amounts were 3v / v%, 2v / v%, and 3v / v%, respectively, under anoxic conditions at 38°C, 150r / min, and fermented for 56h, filtered, washed with solids, and the culture solution was collected and concentrated to obtain a mixed culture solution containing 10 11 cfu / mL; the filtrate was freeze-dried to obtain the fermentation product;

[0082] S8. Preparation of prebiotics: 6 parts by weight of inulin, 15 parts by weight of sodium alginate, and 5 parts by weight of carboxymethyl pachymaran were mixed to obtain prebiotics;

[0083] S9. Encapsulation: Add 7 parts by weight of the chelated Mg-Zn-highland barley-rice bran protein peptide prepared in step S5 to 50 parts by weight of the mixed bacterial solution prepared in step S7, add 17 parts by weight of the prebiotics prepared in step S7 and 1 part by weight of lecithin, stir and mix for 15 minutes to obtain an aqueous phase; add 120 parts by weight of the aqueous phase to 200 parts by weight of fish oil, emulsify at 10000 r / min for 15 minutes, add 20 parts by weight of 7wt% calcium chloride solution dropwise, cure at room temperature for 30 minutes, centrifuge, wash, and dry to obtain probiotics-prebiotics-protein peptide embedded particles;

[0084] S10. Preparation of a probiotic composition for preventing and controlling diabetes: 5 parts by weight of the sulfated modified polysaccharide prepared in step S2, 4 parts by weight of the active polyphenol-flavonoids prepared in step S3, 10 parts by weight of the fermentation product prepared in step S7, and 12 parts by weight of the probiotic-prebiotic-protein peptide embedded particles prepared in step S9 are stirred and mixed for 15 minutes to prepare a probiotic composition for preventing and controlling diabetes.

[0085] Example 3

[0086] This embodiment provides a method for preparing a probiotic composition for preventing and controlling diabetes, which specifically comprises the following steps:

[0087] S1. Extraction of active polysaccharides: 8.5 parts by weight of black fungus and 4 parts by weight of shiitake mushrooms were washed, dried, and crushed to obtain a mixed powder 1, which was added to water. The solid-liquid ratio of the mixed powder 1 to water was 1:6 g / mL. The mixture was heated to boiling and extracted for 4 hours. The solid 1 was collected by filtration. Ethanol was added to the filtrate until the ethanol content of the system was 80 wt %. The mixture was precipitated for 3 hours, centrifuged, the solid was collected, washed, and dried to obtain active polysaccharides.

[0088] S2. Sulfated modified polysaccharide: In an ice water bath, 27 parts by weight of concentrated sulfuric acid and 8.5 parts by weight of n-butanol were mixed, 0.4 parts by weight of ammonium sulfate and 4 parts by weight of the active polysaccharide obtained in step S1 were added, the reaction was stirred for 1 hour, the pH value of the solution was adjusted to neutral, ethanol was added until the ethanol content of the system was 80wt%, and the precipitation was carried out for 3 hours, centrifuged, the precipitate was collected, washed, and dried to obtain a sulfated modified polysaccharide;

[0089] S3. Extraction of active polyphenols-flavonoids: 11 parts by weight of noni pomace, 8.5 parts by weight of blackberry pomace, and 6 parts by weight of purple garlic were washed, dried, crushed and mixed to obtain a mixed powder 2, 11 parts by weight of the mixed powder 2 were added with 17 parts by weight of a deep eutectic solvent and 13 parts by weight of a 55wt% ethanol aqueous solution, 1350W ultrasonic assisted, heated to 60°C, extracted for 1.5h, centrifuged, filtered, and solid 2 was collected, the filtrate was enriched and recovered with a macroporous resin for polyphenols and flavonoids, the obtained polyphenols and flavonoids were mixed uniformly, and active polyphenols-flavonoids were obtained;

[0090] The deep eutectic solvent is lactic acid and choline chloride in a molar ratio of 2:1;

[0091] The flavonoids were enriched and recovered by using macroporous resin AB-8 and eluted with 60% ethanol; the polyphenols were enriched and recovered by using NKA-2 and eluted with 30% ethanol;

[0092] S4. Preparation of enzymatic protein peptide: 13 parts by weight of highland barley and 4 parts by weight of rice bran were washed, dried, crushed and mixed to obtain a mixed powder 3, added to water, the solid-liquid ratio of the mixed powder 3 to water was 1:4 g / mL, a composite enzyme was added, the addition amount was 1.5wt% of the total mass of the system, enzymolysis was performed at 47°C for 3h, filtered, solid 3 was collected, the filtrate was dialyzed with a dialysis bag with a pore size of 4kDa for 3h, and the dialyzate was freeze-dried to obtain highland barley-rice bran protein peptide;

[0093] The composite enzyme is papain and neutral protease, with a mass ratio of 6:1.5;

[0094] S5. Metal ion chelation: 17 parts by weight of the highland barley - rice bran protein peptide obtained in step S4 was dissolved in 200 parts by weight of water, 1.5 parts by weight of zinc nitrate and 3 parts by weight of magnesium nitrate were added, the reaction was stirred for 25 min, dialyzed for 3 h with a dialysis bag having a pore size of 4 kDa, and the dialysate was freeze-dried to obtain a chelated Mg-Zn-highland barley - rice bran protein peptide;

[0095] S6. Activation of fermentation bacteria: Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 were inoculated into Gao's medium respectively, and activated and cultured for 26 h at 37°C and 170 r / min under anoxic conditions. The obtained bacterial seed liquid had a bacterial count of 4×10 8 cfu / mL;

[0096] S7. Fermentation: 11 parts by weight of solid 1, 8.5 parts by weight of solid 2, and 6 parts by weight of solid 3 were mixed and added to 500 parts by weight of water, sterilized, and inoculated with the seed solution of Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 obtained in step S6, and the inoculation amounts were 2v / v%, 1.5v / v%, and 2.5v / v%, respectively, under anaerobic conditions, at 37°C, 135r / min, and fermented for 52h, filtered, washed with solids, and the culture solution was collected and concentrated to obtain a mixed culture solution containing 10 11 cfu / mL; the filtrate was freeze-dried to obtain the fermentation product;

[0097] S8. Preparation of prebiotics: 5 parts by weight of inulin, 13.5 parts by weight of sodium alginate, and 4 parts by weight of carboxymethyl pachymaran were mixed to obtain prebiotics;

[0098] S9. Encapsulation: Add 6 parts by weight of the chelated Mg-Zn-barley-rice bran protein peptide prepared in step S5 to 40 parts by weight of the mixed bacterial solution prepared in step S7, add 16 parts by weight of the prebiotics prepared in step S7 and 0.7 parts by weight of lecithin, stir and mix for 15 minutes to obtain an aqueous phase; add 110 parts by weight of the aqueous phase to 200 parts by weight of fish oil, emulsify at 10000 r / min for 15 minutes, add 20 parts by weight of 6wt% calcium chloride solution dropwise, solidify at room temperature for 25 minutes, centrifuge, wash, and dry to obtain probiotics-prebiotics-protein peptide embedded particles;

[0099] S10. Preparation of a probiotic composition for preventing and controlling diabetes: 4 parts by weight of the sulfated modified polysaccharide prepared in step S2, 3 parts by weight of the active polyphenol-flavonoids prepared in step S3, 8.5 parts by weight of the fermentation product prepared in step S7, and 11 parts by weight of the probiotic-prebiotic-protein peptide embedded particles prepared in step S9 were stirred and mixed for 15 minutes to prepare a probiotic composition for preventing and controlling diabetes.

[0100] Example 4

[0101] Compared with Example 3, the difference is that the complex enzyme is a single papain.

[0102] Example 5

[0103] Compared with Example 3, the difference is that the complex enzyme is a single neutral protease.

[0104] Comparative Example 1

[0105] Compared with Example 3, the difference is that step S2 is not performed, and the active polysaccharide prepared in step S1 is added in step S10.

[0106] The details are as follows:

[0107] S10. Preparation of a probiotic composition for preventing and controlling diabetes: 4 parts by weight of the active polysaccharide prepared in step S1, 3 parts by weight of the active polyphenol-flavonoid prepared in step S3, 8.5 parts by weight of the fermentation product prepared in step S7, and 11 parts by weight of the probiotic-prebiotic-protein peptide-encapsulated particles prepared in step S9 were stirred and mixed for 15 minutes to prepare a probiotic composition for preventing and controlling diabetes.

[0108] Comparative Example 2

[0109] Compared with Example 3, the difference is that in step S3, the deep eutectic solvent is replaced by an equal amount of 55 wt % ethanol aqueous solution.

[0110] The details are as follows:

[0111] S3. Extraction of active polyphenols-flavonoids: 11 parts by weight of noni pomace, 8.5 parts by weight of blackberry pomace, and 6 parts by weight of purple garlic were washed, dried, crushed and mixed to obtain a mixed powder 2, 11 parts by weight of the mixed powder 2 were added to 30 parts by weight of a 55wt% ethanol aqueous solution, 1350W ultrasonic assisted, heated to 60°C, extracted for 1.5h, centrifuged, filtered, and solid 2 was collected, the filtrate was enriched and recovered with a macroporous resin for polyphenols and flavonoids, the obtained polyphenols and flavonoids were mixed uniformly, and active polyphenols-flavonoids were obtained;

[0112] Macroporous resin AB-8 was used to enrich and recover flavonoids, and 60% ethanol was used for elution; NKA-2 was used to enrich and recover polyphenols, and 30% ethanol was used for elution.

[0113] Comparative Example 3

[0114] Compared with Example 3, the difference is that no complex enzyme is added in step S4.

[0115] The details are as follows:

[0116] S4. Preparation of enzymatic protein peptide: 13 parts by weight of highland barley and 4 parts by weight of rice bran were washed, dried, crushed and mixed uniformly to obtain mixed powder 3, which was added into water with a solid-liquid ratio of the mixed powder 3 to water being 1:4 g / mL. The mixture was heated and extracted at 47°C for 3 h, filtered, and solid 3 was collected. The filtrate was dialyzed with a dialysis bag with a pore size of 4 kDa for 3 h, and the dialyzate was freeze-dried to obtain highland barley-rice bran protein.

[0117] Comparative Example 4

[0118] Compared with Example 3, the difference is that zinc nitrate is not added in step S5.

[0119] The details are as follows:

[0120] S5. Metal ion chelation: Dissolve 17 parts by weight of the highland barley-rice bran protein peptide obtained in step S4 in 200 parts by weight of water, add 4.5 parts by weight of magnesium nitrate, stir the reaction for 25 minutes, dialyze for 3 hours using a dialysis bag with a pore size of 4 kDa, and freeze-dry the dialysate to obtain the chelated Mg-highland barley-rice bran protein peptide.

[0121] Comparative Example 5

[0122] Compared with Example 3, the difference is that magnesium nitrate is not added in step S5.

[0123] The details are as follows:

[0124] S5. Metal ion chelation: 17 parts by weight of the highland barley-rice bran protein peptide obtained in step S4 was dissolved in 200 parts by weight of water, 4.5 parts by weight of zinc nitrate was added, the reaction was stirred for 25 minutes, dialyzed for 3 hours using a dialysis bag with a pore size of 4 kDa, and the dialysate was freeze-dried to obtain a chelated Zn-highland barley-rice bran protein peptide.

[0125] Comparative Example 6

[0126] Compared with Example 3, the difference is that step S5 is not performed, and the highland barley-rice bran protein peptide prepared in step S4 is added in step S9.

[0127] The details are as follows:

[0128] S9. Encapsulation: Add 6 parts by weight of highland barley-rice bran protein peptide prepared in step S4 to 40 parts by weight of the mixed bacterial solution prepared in step S7, add 16 parts by weight of the prebiotic prepared in step S7 and 0.7 parts by weight of lecithin, stir and mix for 15 minutes to prepare an aqueous phase; add 110 parts by weight of the aqueous phase to 200 parts by weight of fish oil, emulsify at 10000 r / min for 15 minutes, dropwise add 20 parts by weight of 6wt% calcium chloride solution, solidify at room temperature for 25 minutes, centrifuge, wash, and dry to prepare probiotics-prebiotics-protein peptide embedded particles.

[0129] Comparative Example 7

[0130] Compared with Example 3, the difference is that the seed liquid of Bifidobacterium lactis Bla019 is not inoculated in step S7.

[0131] The details are as follows:

[0132] S7. Fermentation: 11 parts by weight of solid 1, 8.5 parts by weight of solid 2, and 6 parts by weight of solid 3 were mixed and added to 500 parts by weight of water, sterilized, and inoculated with the long Bifidobacterium BL5b and breve Bifidobacterium BB033 seed solution prepared in step S6, the inoculation amounts were 1.5 v / v%, 2.5 v / v%, respectively, under anaerobic conditions, 37 ° C, 135 r / min, fermentation culture for 52h, filtered, washed with solids, collected and concentrated to obtain a mixed bacterial solution containing 10 11 cfu / mL; the filtrate was freeze-dried to obtain the fermentation product.

[0133] Comparative Example 8

[0134] Compared with Example 3, the difference is that the seed liquid of Bifidobacterium longum BL5b is not inoculated in step S7.

[0135] The details are as follows:

[0136] S7. Fermentation: 11 parts by weight of solid 1, 8.5 parts by weight of solid 2, and 6 parts by weight of solid 3 were mixed and added to 500 parts by weight of water, sterilized, and inoculated with the seed solution of Bifidobacterium lactis Bla019 and Bifidobacterium breve BB033 obtained in step S6, the inoculation amounts were 2v / v% and 2.5v / v%, respectively, under anaerobic conditions, at 37°C, 135r / min, and the fermentation culture was carried out for 52h, filtered, the solid was washed, the bacterial solution was collected, and concentrated to obtain a mixed bacterial solution containing 10 11 cfu / mL; the filtrate was freeze-dried to obtain the fermentation product.

[0137] Comparative Example 9

[0138] Compared with Example 3, the difference is that the seed liquid of Bifidobacterium breve BB033 is not inoculated in step S7.

[0139] The details are as follows:

[0140] S7. Fermentation: 11 parts by weight of solid 1, 8.5 parts by weight of solid 2, and 6 parts by weight of solid 3 were mixed and added to 500 parts by weight of water, sterilized, and inoculated with the seed solution of Bifidobacterium lactis Bla019 and Bifidobacterium longum BL5b obtained in step S6, the inoculation amounts were 2v / v% and 1.5v / v%, respectively, under anaerobic conditions, at 37°C, 135r / min, and the fermentation culture was carried out for 52h, filtered, the solid was washed, the bacterial solution was collected, and concentrated to obtain a mixed bacterial solution containing 10 11 cfu / mL; the filtrate was freeze-dried to obtain the fermentation product.

[0141] Comparative Example 10

[0142] Compared with Example 3, the difference is that in step S8, only sodium alginate is used.

[0143] The details are as follows:

[0144] S8. Preparation of prebiotics: Sodium alginate is used as prebiotics.

[0145] Comparative Example 11

[0146] Compared with Example 3, the difference is that the chelated Mg-Zn-highland barley-rice bran protein peptide is not added in step S9.

[0147] The details are as follows:

[0148] S9. Encapsulation: Add 16 parts by weight of the prebiotics prepared in step S7 and 0.7 parts by weight of lecithin to 40 parts by weight of the mixed bacterial solution prepared in step S7, stir and mix for 15 minutes to prepare an aqueous phase; add 110 parts by weight of the aqueous phase to 200 parts by weight of fish oil, emulsify at 10000 r / min for 15 minutes, dropwise add 20 parts by weight of 6wt% calcium chloride solution, solidify at room temperature for 25 minutes, centrifuge, wash, and dry to prepare probiotic-prebiotic-protein peptide encapsulated particles.

[0149] Comparative Example 12

[0150] Compared with Example 3, the difference is that no sulfated modified polysaccharide is added in step S10.

[0151] The details are as follows:

[0152] S10. Preparation of a probiotic composition for preventing and controlling diabetes: 3 parts by weight of the active polyphenol-flavonoids prepared in step S3, 8.5 parts by weight of the fermentation product prepared in step S7, and 11 parts by weight of the probiotic-prebiotic-protein peptide-encapsulated particles prepared in step S9 were stirred and mixed for 15 minutes to prepare a probiotic composition for preventing and controlling diabetes.

[0153] Comparative Example 13

[0154] Compared with Example 3, the difference is that active polyphenol-flavonoids are not added in step S10.

[0155] The details are as follows:

[0156] S10. Preparation of a probiotic composition for preventing and controlling diabetes: 4 parts by weight of the sulfated modified polysaccharide prepared in step S2, 8.5 parts by weight of the fermentation product prepared in step S7, and 11 parts by weight of the probiotic-prebiotic-protein peptide embedded particles prepared in step S9 were stirred and mixed for 15 minutes to prepare a probiotic composition for preventing and controlling diabetes.

[0157] Comparative Example 14

[0158] Compared with Example 3, the difference is that no fermentation product is added in step S10.

[0159] The details are as follows:

[0160] S10. Preparation of a probiotic composition for preventing and controlling diabetes: 4 parts by weight of the sulfated modified polysaccharide prepared in step S2, 3 parts by weight of the active polyphenol-flavonoids prepared in step S3, and 11 parts by weight of the probiotic-prebiotic-protein peptide-encapsulated particles prepared in step S9 were stirred and mixed for 15 minutes to prepare a probiotic composition for preventing and controlling diabetes.

[0161] Comparative Example 15

[0162] Compared with Example 3, the difference is that no probiotic-prebiotic-protein peptide embedded particles are added in step S10.

[0163] The details are as follows:

[0164] S10. Preparation of a probiotic composition for preventing and controlling diabetes: 4 parts by weight of the sulfated modified polysaccharide prepared in step S2, 3 parts by weight of the active polyphenol-flavonoids prepared in step S3, and 8.5 parts by weight of the fermentation product prepared in step S7 are stirred and mixed for 15 minutes to prepare a probiotic composition for preventing and controlling diabetes.

[0165] Test Example 1

[0166] The probiotic compositions for preventing and controlling diabetes prepared in Examples 1-5 and Comparative Examples 1-15 were added to warm water at 37° C. and incubated for 1 hour to prepare a mixed solution with a concentration of 10 mg / mL.

[0167] 1. Inhibition of α-amylase

[0168] Mix 1 mL of sample mixture with 1 mL of 10 U / mL α-amylase solution, incubate at 37°C for 10 min, add 1 mL of 1 wt% soluble starch, incubate at 37°C for 10 min, then add 0.5 mL of 1 wt% DNS colorimetric agent, mix well, heat in boiling water bath for 5 min, cool to room temperature, centrifuge, transfer supernatant to 25 mL volumetric flask, make up to volume with ultrapure water, and measure absorbance at 510 nm. Repeat 3 times for each sample. Ultrapure water was used as blank control group, and acarbose was used as positive control group.

[0169] α-Amylase inhibition rate (%) = [1-(A1-A2) / (A3-A4)] × 100%

[0170] Wherein: A1 is the absorbance value of the sample group, A2 is the absorbance value of the sample without enzyme, A3 is the absorbance value of the blank control group, and A4 is the absorbance value of the blank control without enzyme.

[0171] 2. Inhibition of α-glucosidase

[0172] Take 100 μL of sample solution and 0.5 mg / mL enzyme solution, keep warm in a 37℃ water bath for 5 min, add 200 μL of 5 mmol / L PNPG solution and mix well, react at 37℃ for 30 min, then add 2 mL of 0.2 mol / L Na2CO3 solution to terminate the reaction, and measure the absorbance at 405 nm. Acarbose was used as the positive control group.

[0173] α-glucosidase inhibition rate (%) = [1-(A 2-A1 ) / A0]×100%.

[0174] Wherein: A0 is the absorbance value of the blank group, A1 is the absorbance value of the PNPG solution replaced by phosphate buffer, and A2 is the absorbance value of the sample group.

[0175] The results are shown in Table 1.

[0176] Table 1

[0177]

[0178]

[0179] It can be seen from the above table that the probiotic compositions for preventing and controlling diabetes prepared in Examples 1-3 of the present invention have a good inhibitory effect on both α-amylase and α-glucosidase.

[0180] Test Example 2

[0181] Modeling: SPF Kunming mice with a body weight of 18-22g were fed adaptively for 7 days, and 10 mice were randomly selected as the normal group and fed with normal feed. The rest of the mice were fed with high-sugar and high-fat feed. After 4 consecutive weeks of feeding, they were fed with high-sugar and high-fat feed and intraperitoneally injected with 50mg / kg streptozotocin solution for 3 consecutive days. The injection volume was 0.1mL / 10g, and the normal group mice were injected with the same volume of normal saline. After the end of feeding, the high-sugar and high-fat fed mice were fasted for 12h but not water, and blood was collected by acupuncture on the tail vein to measure the fasting blood sugar of the mice. The mice with fasting blood sugar greater than 11.1mmol / L were selected as diabetic model mice.

[0182] Grouping and administration: The mice with successfully constructed diabetes models were randomly divided into a positive drug group, Example 1-5 group, and Comparative Example 1-15 group, with 6 mice in each group. The positive drug group was gavaged with 200 mg / kg of metformin hydrochloride every day, and the Example 1-5 and Comparative Example 1-15 groups were gavaged with 200 mg / kg of the probiotic composition for preventing and controlling diabetes every day. The normal group was gavaged with an equal amount of physiological saline every day, and the same feed and drinking water were fed every day. The mice were fed for 28 days. The fasting blood glucose content of the mice was measured every 14 days. The results are shown in Table 2.

[0183] Table 2

[0184]

[0185]

[0186] Note: * compared with the normal group, P < 0.05; # compared with the model group, P < 0.05.

[0187] After feeding, the eyeballs of the mice were removed to collect blood, and the serum was separated to determine the insulin content, liver glycogen content and glycosylated hemoglobin content, as well as the SOD, GSH-Px and MDA content.

[0188] The results are shown in Tables 3 and 4.

[0189] Table 3

[0190]

[0191]

[0192] Note: * compared with the normal group, P < 0.05; # compared with the model group, P < 0.05.

[0193] Table 4

[0194] Group SOD content (U / mg) GSH-Px content (μmol / L) MDA content (nmol / mg) Normal group 592.25±29.14 488.13±29.51 8.79±1.02 Model Group 301.19±17.55* 250.38±30.18* 19.79±2.24* Positive drug group 515.92±21.58# 454.25±28.58# 9.22±1.18# Example 1 534.25±19.52# 467.92±27.45# 9.01±1.09# Example 2 537.19±20.14# 470.11±25.98# 8.93±1.04# Example 3 540.32±21.54# 472.24±26.86# 8.89±1.14# Example 4 530.14±18.59 462.15±24.52 9.32±1.15 Example 5 528.95±19.52 461.98±25.83 9.39±1.07 Comparative Example 1 525.98±18.19 456.88±23.84 9.57±1.12 Comparative Example 2 523.19±18.95 455.28±22.19 9.60±1.15 Comparative Example 3 524.29±17.85 457.82±22.38 9.45±1.11 Comparative Example 4 525.91±18.53 459.68±21.18 9.41±1.02 Comparative Example 5 524.83±19.29 458.29±20.84 9.43±1.09 Comparative Example 6 520.19±17.58 452.49±18.85 9.50±1.10 Comparative Example 7 515.82±17.93 448.92±16.98 9.62±1.08 Comparative Example 8 516.39±17.04 446.78±15.29 9.66±1.12 Comparative Example 9 515.96±16.58 447.09±14.82 9.64±1.05 Comparative Example 10 518.92±15.82 450.28±15.19 9.58±1.43 Comparative Example 11 514.82±17.82 448.58±20.48 10.89±1.24 Comparative Example 12 510.12±18.29 446.79±22.19 11.28±1.08 Comparative Example 13 513.29±19.27 450.28±21.84 11.02±1.24 Comparative Example 14 514.82±17.28 449.19±20.19 10.75±1.09 Comparative Example 15 503.25±17.58 442.29±17.82 11.78±1.17

[0195] Note: * compared with the normal group, P < 0.05; # compared with the model group, P < 0.05.

[0196] Compared with Example 3, the composite enzyme in Examples 4 and 5 is a single papain or neutral protease. Compared with Example 3, no composite enzyme is added in step S4 in Comparative Example 3. Fasting blood glucose value is improved, the antioxidant effect in the body decreases, the insulin content and the glycogen content decrease, and the glycosylated hemoglobin content increases. Highland barley and rice bran are rich in protein, and the small molecule protein peptides obtained by enzymolysis have good hypoglycemic, hypolipidemic, anti-inflammatory and antioxidant activities, and the small molecule structure makes it easier to be absorbed by the human body.

[0197] Compared with Example 3, Comparative Example 1 did not perform step S2, and the active polysaccharide prepared in step S1 was added in step S10. Compared with Example 3, Comparative Example 12 did not add sulfated modified polysaccharide in step S10. The inhibitory effect on α-amylase and α-glucosidase decreased, the fasting blood glucose value increased, the antioxidant effect in the body decreased, the insulin content and liver glycogen content decreased, and the glycated hemoglobin content increased. Black fungus and shiitake mushrooms are rich in active polysaccharides that lower blood sugar, have the ability to promote insulin secretion and enhance insulin sensitivity, reduce oxidative stress and inflammatory response, and thus improve β cell damage. After the active polysaccharide is extracted, it is modified by sulfation, which further improves the stability of the modified polysaccharide, improves its antioxidant, blood sugar lowering, blood lipid regulating activities, and has a good effect of inhibiting active enzymes such as α-glucosidase and α-amylase. By inhibiting the activity of these enzymes, the starch food intake is reduced and decomposed into oligosaccharides, which are further converted into monosaccharides by α-glucosidase in the small intestine, thereby inhibiting the increase in blood sugar caused by the conversion of food into monosaccharides and absorption into the blood, and inducing liver cells to produce insulin, so that postprandial blood sugar can be well stabilized. In addition, the modified polysaccharide can also increase the probiotics, promote the production of short-chain fatty acids, promote the intestinal peristalsis of rats, reduce the pH in the intestine, provide a good living environment for probiotics, promote the increase in the content of short-chain fatty acids (acetic acid, propionic acid, isobutyric acid, etc.) in the body, and reduce blood sugar.

[0198] Comparative Example 2 Compared with Example 3, the deep eutectic solvent in step S3 is replaced by an equal amount of 55wt% ethanol aqueous solution. Comparative Example 13 Compared with Example 3, active polyphenol-flavonoids are not added in step S10. The inhibitory effect on α-amylase and α-glucosidase is reduced, the fasting blood glucose value is improved, the antioxidant effect in the body is reduced, the insulin content and the glycogen content are reduced, and the glycosylated hemoglobin content is increased. Noni is a fruit containing multiple functional active ingredients such as vitamins, amino acids, phenolic compounds, organic acids, polysaccharides, alkaloids, anthraquinones, cyclopentadiene compounds, scopolamine, etc., with good anti-tumor, anti-thrombotic, antibacterial, hypoglycemic activity, as well as activating the immune system, neutralizing free radicals, balancing cell function, cleaning blood and regulating cholesterol; blackberry is also rich in anthocyanins, flavonoids and other active substances, with antioxidant, hypoglycemic, prevention of inflammatory diseases and cardiovascular diseases and anti-cancer effects. Purple garlic is rich in sulfur compounds, volatile oils, amino acids, polysaccharides, vitamins, saponin compounds, polyphenol compounds, flavonoid compounds, bioactive enzymes and trace elements, and has good anti-inflammatory, anti-oxidation, hypoglycemic, cardiovascular disease prevention and treatment, anti-tumor, hypolipidemic and other activities. The present invention utilizes the pomace (noni pomace, blackberry pomace) after juicing in industrialization, and extracts the polyphenol composition and flavonoid composition with good anti-inflammatory and antioxidant activities together with the purple garlic, and extracts them through deep eutectic solvent, which is economical, non-toxic, recyclable, environmentally friendly, and has a high extraction rate for polyphenols and flavonoids. Under the auxiliary extraction of ultrasound, the extraction rate of the original polyphenols and flavonoids is greatly improved, and the obtained active polysaccharide-flavonoid has good antioxidant and anti-inflammatory activities, has good inhibitory activity on α-glucosidase and α-amylase, and also plays a good role in regulating blood sugar.

[0199] Compared with Example 3, in Comparative Examples 4 and 5, zinc nitrate or magnesium nitrate was not added in step S5. Compared with Example 3, in Comparative Example 6, step S5 was not performed, and the highland barley-rice bran protein peptide prepared in step S4 was added in step S9. Fasting blood glucose value increased, insulin content and glycogen content decreased, and glycosylated hemoglobin content increased. Compared with Example 3, in Comparative Example 11, chelated Mg-Zn-highland barley-rice bran protein peptide was not added in step S9. Highland barley and rice bran are rich in protein. The small molecule protein peptides obtained by enzymolysis have good hypoglycemic, hypolipidemic, anti-inflammatory and antioxidant activities, and the small molecule structure makes it easier to be absorbed by the human body. After the obtained protein peptide is further chelated with trace element ions Mg ions and Zn ions through coordination bonds, protein peptides containing trace elements Mg and Zn are obtained. Magnesium or zinc elements can promote insulin secretion, thereby playing a role in regulating blood sugar.

[0200] Compared with Example 3, in Comparative Examples 7, 8, and 9, Bifidobacterium lactis Bla019 strain seed liquid, Bifidobacterium longum BL5b strain seed liquid, or Bifidobacterium breve BB033 strain seed liquid was not inoculated in step S7. Compared with Example 3, in Comparative Example 15, probiotic-prebiotic-protein peptide-encapsulated particles were not added in step S10. The inhibitory effect on α-amylase and α-glucosidase decreased, the fasting blood glucose value increased, the antioxidant effect in the body decreased, the insulin content and the glycogen content decreased, and the glycated hemoglobin content increased. Probiotics regulate blood sugar by regulating the balance of intestinal flora, intestinal immunity, the microorganism-gut-brain axis, the microorganism-gut-liver axis, etc. The added Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 of the present invention can act synergistically and play a good role in regulating blood sugar. On the one hand, after these probiotics enter the intestine, they can rapidly proliferate and consume glucose, and by reducing chronic low-grade inflammation, reduce serum lipopolysaccharide, free fatty acids, TNF-α, IL-6, IL-8 levels and increase IL-10 levels, significantly improve the inflammatory state induced by serum lipopolysaccharide, reduce oxidative stress, improve insulin resistance, etc. to achieve the effect of regulating blood sugar. At the same time, these probiotics can produce a large amount of postbiotics, including microbial metabolites, proteins, lipids, carbohydrates, vitamins, organic acids, cell wall components or other complex molecules, etc., participate in immune regulation or stimulate intestinal cells to play a role, wherein acetate has been shown to reduce inflammation and insulin sensitivity and improve glucose tolerance by regulating fasting insulin and glucagon levels. The dipeptide in the bacterial wall component can regulate the secretion of GLP-1 and improve insulin sensitivity and glucose tolerance through the NOD2 receptor. Combinations of bacteria, synbiotics, and postbiotics have good biological activity and can prevent and alleviate metabolic diseases such as type 2 diabetes. Bacteriocins can protect pancreatic islets, promote pancreatic function, inhibit α-glucosidase, and regulate blood sugar.

[0201] Comparative Example 14 Compared with Example 3, no fermentation product is added in step S10. The inhibitory effect on alpha-amylase and alpha-glucosidase decreases, the fasting blood sugar value increases, the antioxidant effect in the body decreases, the insulin content and the glycogen content decrease, and the glycosylated hemoglobin content increases. The probiotics added by the present invention can also ferment the solid waste residue of the preceding step, further rupture the cell wall, promote the dissolution of active components in the plant, and produce a large amount of substances such as short-chain fatty acids, and the obtained fermentation product also has good antioxidant and anti-inflammatory effects, and can well play a role in regulating blood sugar, blood lipids and other metabolic effects.

[0202] Comparative Example 10 Compared with Example 3, step S8 is a single sodium alginate. Fasting blood sugar value improves, antioxidant effect in vivo decreases, insulin content, glycogen content decreases, and glycosylated hemoglobin content increases. If probiotics directly enter the human body, they are often destroyed and inactivated by gastric acid, and cannot smoothly reach the intestinal tract, and play their effect. Therefore, the present invention is embedded with probiotics and chelated protein peptides, on the one hand, the embedded wall material is a class of polysaccharide substances, mixed embedding has a good effect of gastric acid resistance and choline resistance, on the other hand, these polysaccharide wall materials are also a kind of good prebiotics, after the intestinal tract is degraded and broken, the probiotics inside are dissolved, colonized in the intestinal tract, and the broken prebiotic wall material can be effectively used by prebiotics, thereby greatly promoting the reproduction of probiotics and the secretion of postbiotics such as short-chain fatty acids, greatly promoting the regulation of probiotics on blood sugar, and protein peptides also avoid the inactivation of gastric acid, enter the intestinal tract can be directly absorbed by the human body, play a good antioxidant, anti-inflammatory, blood sugar regulating effect.

[0203] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing a probiotic composition for preventing and controlling diabetes, characterized in that: Extract black fungus and shiitake mushroom polysaccharides and perform sulfate modification to obtain sulfated modified polysaccharides; extract noni pomace, blackberry pomace and purple garlic through deep eutectic solvent to obtain active polyphenol-flavonoids; enzymolyze highland barley and rice bran, chelate metal ions to obtain chelated Mg-Zn-highland barley-rice bran protein peptides; inoculate fermentation bacteria into the solid residue produced in the above process for fermentation, filter, wash the solid to collect the fermentation liquid, freeze-dry the filtrate to obtain the fermentation product, mix the fermentation liquid with prebiotics and chelated Mg-Zn-highland barley-rice bran protein peptides to obtain probiotic-prebiotic-protein peptide embedded particles, and mix with the fermentation product, sulfated modified polysaccharides and active polyphenol-flavonoids to obtain a probiotic composition for preventing and controlling diabetes.

2. The preparation method according to claim 1, characterized in that: The following steps are involved: S1. Extraction of active polysaccharides: Wash black fungus and shiitake mushrooms, dry and crush them to obtain a mixed powder 1, add them into water, heat them to boiling for extraction, filter and collect solid 1, add ethanol to the filtrate for precipitation, centrifuge, collect solids, wash and dry them to obtain active polysaccharides; S2. Sulfated modified polysaccharide: In an ice water bath, concentrated sulfuric acid and n-butanol were mixed, ammonium sulfate and the active polysaccharide obtained in step S1 were added, the reaction was stirred, the pH value of the solution was adjusted to neutral, ethanol was added for precipitation, centrifugation was performed, the precipitate was collected, washed, and dried to obtain a sulfated modified polysaccharide; S3. Extraction of active polyphenols-flavonoids: Noni pomace, blackberry pomace and purple garlic are washed, dried, crushed and mixed to obtain a mixed powder 2, a deep eutectic solvent and an ethanol solution are added, ultrasonic-assisted heating extraction is performed, centrifugation is performed, filtering is performed, solid 2 is collected, polyphenols and flavonoids are enriched and recovered in the filtrate using a macroporous resin, and the obtained polyphenols and flavonoids are uniformly mixed to obtain active polyphenols-flavonoids; S4. Preparation of enzymatic protein peptide: The highland barley and rice bran were washed, dried, crushed and mixed to obtain a mixed powder 3, added to water, added with a composite enzyme for enzymatic hydrolysis, filtered, solid 3 was collected, the filtrate was dialyzed, and the dialyzate was freeze-dried to obtain highland barley - rice bran protein peptide; S5. Metal ion chelation: The highland barley - rice bran protein peptide obtained in step S4 was dissolved in water, zinc salt and magnesium salt were added, the reaction was stirred, dialyzed, and the dialyzate was freeze-dried to obtain a chelated Mg-Zn-highland barley - rice bran protein peptide; S6. Activation of fermentation bacteria: Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 were inoculated into Gao's medium and activated under anoxic conditions to obtain a seed solution of the bacteria; S7 fermentation: solid 1, solid 2, solid 3 was mixed and added to water, sterilized, inoculated with the seed solution of Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, Bifidobacterium breve BB033 obtained in step S6, fermented under anoxic conditions, filtered, washed with solids, the culture solution was collected, concentrated to obtain a mixed culture solution; the filtrate was freeze-dried to obtain a fermentation product; S8. Preparation of prebiotics: mixing inulin, sodium alginate and carboxymethyl pachymaran to prepare prebiotics; S9. Encapsulation: adding the chelated Mg-Zn-highland barley-rice bran protein peptide obtained in step S5 to the mixed bacterial solution obtained in step S7, adding the prebiotics and lecithin obtained in step S7, stirring and mixing uniformly to obtain an aqueous phase; adding the aqueous phase to fish oil, emulsifying, adding a calcium chloride solution dropwise, solidifying at room temperature, centrifuging, washing, and drying to obtain probiotic-prebiotic-protein peptide embedded particles; S10. Preparation of a probiotic composition for preventing and controlling diabetes: uniformly mix the sulfated modified polysaccharide prepared in step S2, the active polyphenol-flavonoids prepared in step S3, the fermentation product prepared in step S7, and the probiotic-prebiotic-protein peptide-encapsulated particles prepared in step S9 to prepare a probiotic composition for preventing and controlling diabetes.

3. The preparation method according to claim 2, characterized in that: In step S1, the mass ratio of black fungus and shiitake mushroom is 7-10:3-5, the solid-liquid ratio of the mixed powder 1 and water is 1:5-7 g / mL, the extraction time is 3-5 hours, ethanol is added until the ethanol content of the system is 75-85wt%, and the precipitation time is 2-4 hours; in step S2, the mass ratio of concentrated sulfuric acid, n-butanol, ammonium sulfate and active polysaccharide is 22-35:7-10:0.3-0.5:3-5, the stirring reaction time is 0.5-1 hour, ethanol is added until the ethanol content of the system is 75-85wt%, and the precipitation time is 2-4 hours.

4. The preparation method according to claim 2, characterized in that: In step S3, the mass ratio of the noni pomace, the blackberry pomace, and the purple garlic is 10-12:7-10:5-7, the mass ratio of the mixed powder 2, the deep eutectic solvent, and the ethanol solution is 10-12:15-20:12-15, the concentration of the ethanol solution is 50-60wt%, the deep eutectic solvent is lactic acid and choline chloride, the molar ratio is 1.8-2.2:1, the temperature of the ultrasonic assisted heating extraction is 55-65°C, the time is 1-2h, the ultrasonic power is 1200-1500W, and the macroporous resin is selected from NKA-9, D101, HPD 600, XDA-2, X-5, LSA-10, NKI-9, SP-825, AB-8; in step S4, the mass ratio of highland barley to rice bran is 12-15:3-5, the solid-liquid ratio of the mixed powder 3 and water is 1:3-5 g / mL, the composite enzyme is papain and neutral protease, the mass ratio is 5-7:1-2, the addition amount of the composite enzyme is 1-2wt% of the total mass of the system, the temperature of the enzymolysis is 45-50°C, the time is 2-4h, the pore size of the dialysis bag used for dialysis is 3-5kDa, and the dialysis time is 2-4h.

5. The preparation method according to claim 2, characterized in that: The mass ratio of highland barley-rice bran protein peptide, zinc salt and magnesium salt in step S5 is 15-20:1-2:2-4, the magnesium salt is selected from at least one of magnesium chloride, magnesium sulfate and magnesium nitrate, the zinc salt is selected from at least one of zinc chloride, zinc sulfate and zinc nitrate, the stirring reaction time is 20-30min, the dialysis bag pore size for dialysis is 3-5kDa, and the dialysis time is 2-4h; the conditions of activation culture in step S6 are 36-38°C, 150-200r / min, activation culture 24-28h, and the bacterial content of the bacterial seed liquid is 10 8 -10 9 cfu / mL.

6. The preparation method according to claim 2, characterized in that: The mass ratio of solid 1, solid 2, solid 3 and water in step S7 is 10-12:7-10:5-7:500, the inoculation amount of the seed solution of Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 is 1-3v / v%, 1-2v / v%, and 2-3v / v%, respectively, the fermentation culture conditions are 36-38°C, 120-150r / min, and the fermentation culture is 48-56h, and the bacterial content in the mixed bacterial solution is 10 10 -10 11 cfu / mL; the mass ratio of inulin, sodium alginate and carboxymethyl pachymaran in step S8 is 4-6:12-15:3-5.

7. The preparation method according to claim 2, characterized in that: The mass ratio of the chelated Mg-Zn-highland barley-rice bran protein peptide, the mixed bacterial solution, the prebiotics and the lecithin in step S9 is 5-7:30-50:15-17:0.5-1; the mass ratio of the sulfated modified polysaccharide, the active polyphenol-flavonoids, the fermentation product, and the probiotic-prebiotic-protein peptide embedded particles in step S10 is 3-5:2-4:7-10:10-12.

8. The preparation method according to claim 2, characterized in that: The specific steps include: S1. Extraction of active polysaccharides: 7-10 parts by weight of black fungus and 3-5 parts by weight of shiitake mushrooms were washed, dried, and crushed to obtain a mixed powder 1, added to water, the solid-liquid ratio of the mixed powder 1 to water was 1:5-7 g / mL, heated to boiling and extracted for 3-5 hours, filtered, and solid 1 was collected, ethanol was added to the filtrate until the ethanol content of the system was 75-85wt%, precipitated for 2-4 hours, centrifuged, the solid was collected, washed, and dried to obtain active polysaccharides; S2. Sulfated modified polysaccharide: In an ice water bath, 22-35 parts by weight of concentrated sulfuric acid and 7-10 parts by weight of n-butanol are mixed, 0.3-0.5 parts by weight of ammonium sulfate and 3-5 parts by weight of the active polysaccharide obtained in step S1 are added, the reaction is stirred for 0.5-1h, the pH value of the solution is adjusted to neutral, ethanol is added to the system ethanol content of 75-85wt%, precipitation is carried out for 2-4h, centrifugation is carried out, the precipitate is collected, washed, and dried to obtain a sulfated modified polysaccharide; S3. Extraction of active polyphenols-flavonoids: 10-12 parts by weight of noni pomace, 7-10 parts by weight of blackberry pomace, and 5-7 parts by weight of purple garlic are washed, dried, crushed and mixed to obtain a mixed powder 2, 10-12 parts by weight of the mixed powder 2 are added with 15-20 parts by weight of a deep eutectic solvent and 12-15 parts by weight of a 50-60wt% ethanol aqueous solution, 1200-1500W ultrasonic-assisted, heated to 55-65°C, extracted for 1-2h, centrifuged, filtered, and solid 2 is collected, the filtrate is enriched and recovered with a macroporous resin for polyphenols and flavonoids, the obtained polyphenols and flavonoids are mixed uniformly, and active polyphenols-flavonoids are obtained; The deep eutectic solvent is lactic acid and choline chloride in a molar ratio of 1.8-2.2:1; Macroporous resin AB-8 was used to enrich and recover flavonoids, and NKA-2 was used to enrich and recover polyphenols. S4. Preparation of enzymatic protein peptide: 12-15 parts by weight of highland barley and 3-5 parts by weight of rice bran were washed, dried, crushed and mixed to obtain a mixed powder 3, added to water, the solid-liquid ratio of the mixed powder 3 and water was 1:3-5g / mL, a complex enzyme was added, the addition amount was 1-2wt% of the total mass of the system, 45-50°C enzymatic hydrolysis for 2-4h, filtered, solid 3 was collected, the filtrate was dialyzed with a dialysis bag with a pore size of 3-5kDa for 2-4h, and the dialyzate was freeze-dried to obtain highland barley-rice bran protein peptide; The complex enzyme is papain and neutral protease, with a mass ratio of 5-7:1-2; S5. Metal ion chelation: 15-20 parts by weight of the highland barley - rice bran protein peptide obtained in step S4 was dissolved in 200 parts by weight of water, 1-2 parts by weight of zinc salt and 2-4 parts by weight of magnesium salt were added, the reaction was stirred for 20-30 min, dialyzed with a dialysis bag with a pore size of 3-5 kDa for 2-4 h, and the dialysate was freeze-dried to obtain a chelated Mg-Zn-highland barley - rice bran protein peptide; S6. Activation of fermentation bacteria: Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, and Bifidobacterium breve BB033 were inoculated into Gao's medium respectively, and activated and cultured for 24-28 hours at 36-38°C and 150-200r / min under anoxic conditions to obtain a bacterial seed solution with a bacterial content of 10 8 -10 9 cfu / mL; S7. Fermentation: 10-12 parts by weight of solid 1, 7-10 parts by weight of solid 2, 5-7 parts by weight of solid 3 were mixed and added to 500 parts by weight of water, sterilized, inoculated with the seed solution of Bifidobacterium lactis Bla019, Bifidobacterium longum BL5b, Bifidobacterium breve BB033 obtained in step S6, and the inoculation amounts were 1-3v / v%, 1-2v / v%, 2-3v / v%, respectively, under anaerobic conditions, 36-38°C, 120-150r / min, fermented and cultured for 48-56h, filtered, washed with solids, the culture solution was collected, concentrated, and a mixed culture solution containing 10 10 -10 11 cfu / mL; the filtrate was freeze-dried to obtain the fermentation product; S8. Preparation of prebiotics: 4-6 parts by weight of inulin, 12-15 parts by weight of sodium alginate, and 3-5 parts by weight of carboxymethyl pachymaran were mixed to obtain prebiotics; S9. Encapsulation: Add 5-7 parts by weight of the chelated Mg-Zn-barley-rice bran protein peptide prepared in step S5 to 30-50 parts by weight of the mixed bacterial solution prepared in step S7, add 15-17 parts by weight of the prebiotic prepared in step S7 and 0.5-1 parts by weight of lecithin, stir and mix evenly to obtain an aqueous phase; add 100-120 parts by weight of the aqueous phase to 200 parts by weight of fish oil, emulsify, add 20 parts by weight of 5-7wt% calcium chloride solution dropwise, cure at room temperature for 20-30min, centrifuge, wash, and dry to obtain probiotics-prebiotics-protein peptide embedded particles; S10. Preparation of a probiotic composition for preventing and controlling diabetes: 3-5 parts by weight of the sulfated modified polysaccharide prepared in step S2, 2-4 parts by weight of the active polyphenol-flavonoids prepared in step S3, 7-10 parts by weight of the fermentation product prepared in step S7, and 10-12 parts by weight of the probiotic-prebiotic-protein peptide embedded particles prepared in step S9 are uniformly mixed to prepare a probiotic composition for preventing and controlling diabetes.

9. A probiotic composition for preventing and controlling diabetes obtained by the preparation method according to any one of claims 1 to 8.

10. Use of the probiotic composition for preventing and controlling diabetes as claimed in claim 9 in the preparation of food and medicine for preventing, treating and assisting in the treatment of type 2 diabetes.

Citation Information

Patent Citations

  • Probiotic composition for regulating metabolism and preparation method thereof

    CN116035205A

  • Composition for treating constipation and preparation method thereof

    CN116832084A